About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Sulfasalazine
- Company
- Eccogene
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 16 recruiting
Efficacy results: Not yet reported
16 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026
Find a Clinical Trial Near Me
See recruiting studies for Sulfasalazine and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT02714634
Clinical Trial Evaluating Methotrexate or Leflunomide + Targeted Therapy Versus Methotrexate or Leflunomide + Sulfasalazine + Hydroxychloroquine in Patients With Rheumatoid Arthritis and Insufficient Response to Methotrexate or Leflunomide
Not yet reported University Hospital, Strasbourg, France 286 participants Est. completion 2029-03 1 siteOther conditions: Rheumatoid Arthritis, Insufficient Response to Methotrexate or LeflunomideView official trial listing → -
Recruiting NCT NCT03414502
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
Not yet reported University of Nebraska 400 participants Est. completion 2029-03 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Recruiting NCT NCT04725422
CHronic Nonbacterial Osteomyelitis International Registry
Seattle Children's Hospital 2000 participants Est. completion 2050-08 1 siteOther conditions: Chronic Nonbacterial Osteomyelitis, Chronic Recurrent Multifocal OsteomyelitisView official trial listing → -
Recruiting NCT NCT05580861
Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line Treatment
Not yet reported, Not yet reported Assistance Publique - Hôpitaux de Paris 64 participants Est. completion 2026-12 13 sites Stand-aloneOther conditions: Acute Myeloid LeukemiaView official trial listing → -
Recruiting NCT NCT05664464
Glutamate Inhibitors in Glioblastoma
Not yet reported, Not yet reported University of Zurich 120 participants Est. completion 2026-12 1 site Stand-aloneOther conditions: GlioblastomaView official trial listing → -
Recruiting NCT NCT05703425
The Effect of Sulfasalazine on CRH Levels in Pregnant Women
Not yet reported Rutgers, The State University of New Jersey 50 participants Est. completion 2028-06-30 1 site Stand-aloneOther conditions: Preterm BirthView official trial listing → -
Recruiting NCT NCT05782335
Analysis of T and B Cell Repertoire Changes in Response to Orencia® (Abatacept) in Rheumatoid Arthritis
Hospital for Special Surgery, New York 72 participants Est. completion 2026-12 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Recruiting NCT NCT06134388
Sulfasalazine in Patients With Metastatic Colorectal Cancer
Not yet reported Tanta University 50 participants Est. completion 2026-09 1 siteOther conditions: Metastatic Colorectal CancerView official trial listing → -
Recruiting NCT NCT06293378
Safety and Effectiveness of Sulfasalazine in the Treatment of Liver Fibrosis/Cirrhosis.
Not yet reported The Second Affiliated Hospital of Chongqing Medical University 330 participants Est. completion 2028-10-10 2 sites Stand-aloneOther conditions: Cirrhosis, Liver, Fibrosis, LiverView official trial listing → -
Recruiting NCT NCT06640309
The Effect of Nicotinamide on the Clinical Outcome of Rheumatoid Arthritis Patients
Not yet reported Ain Shams University 70 participants Est. completion 2025-06 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Recruiting NCT NCT06753565
L-carnitine Supplementation in Rheumatoid Arthritis Patients
Not yet reported German University in Cairo 60 participants Est. completion 2025-06 1 site Stand-aloneOther conditions: Rheumatoid Arthritis (RA)View official trial listing → -
Recruiting NCT NCT06915701
"Effect of Vitamin E (α-Tocopherol) on Clinical Activity and Inflammation in Rheumatoid Arthritis"
Not yet reported, Not yet reported University of Guadalajara 46 participants Est. completion 2027-01-15 2 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Recruiting NCT NCT07138898
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Not yet reported NYU Langone Health 80 participants Est. completion 2028-01 1 site Stand-aloneOther conditions: Rheumatic DiseaseView official trial listing → -
Recruiting NCT NCT07280741
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases Under Immunomodulators
Not yet reported University of Sao Paulo General Hospital 200 participants Est. completion 2028-07-30 1 site Stand-aloneOther conditions: Autoimmune Rheumatic DiseasesView official trial listing → -
Recruiting NCT NCT07416656
Validation of Hemoglobin A1c in Patients With Inflammatory Arthritis Treated With Sulfasalazine
Klavs Würgler Hansen 75 participants Est. completion 2026-10 1 siteType 2 diabetes Other conditions: Inflammatory Arthritis, Diabetes (DM), Rheumatoid Arthritis (RA), Type 1 Diabetes MellitusView official trial listing → -
Recruiting NCT NCT07726368
Study of ECC4703 With Sulfasalazine and Pitavastatin
Not yet reported Eccogene 40 participants Est. completion 2026-12 1 site Stand-aloneMASLD Other conditions: DyslipidaemiaView official trial listing → -
Completed NCT NCT00062465
Treating Rheumatoid Arthritis With Tripterygium Wilfordi Hook F or Sulfasalazine
Not yet reported National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 157 participants Est. completion 2006-03 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00247962
Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 566 participants Est. completion 2008-02 83 sitesOther conditions: Ankylosing SpondylitisView official trial listing → -
Completed NCT NCT00259610
Treatment of Early Aggressive Rheumatoid Arthritis (TEAR)
Not yet reported University of Alabama at Birmingham 755 participants Est. completion 2009-06 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00405275
Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate Therapy
Not yet reported US Department of Veterans Affairs 353 participants Est. completion 2012-05 37 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00410046
Extension Study Evaluating Etanercept in Ankylosing Spondylitis
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 84 participants Est. completion 2008-10 16 sitesOther conditions: Ankylosing SpondylitisView official trial listing → -
Completed NCT NCT00422227
Study Comparing Etanercept With Usual DMARD Therapy in Subjects With Rheumatoid Arthritis in the Asia Pacific Region
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 300 participants Est. completion 2009-03 27 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00520572
A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA)
Not yet reported AstraZeneca 385 participants Est. completion 2009-03 51 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Terminated NCT NCT00521924
Induction of Remission in RA Patients at Low Disease Activity by Additional Infliximab Therapy (Study P04644AM1) (TERMINATED)
Not yet reported Merck Sharp & Dohme LLC 8 participants Est. completion 2008-04Other conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00531817
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis
Not yet reported Hoffmann-La Roche 619 participants Est. completion 2011-03 157 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00554203
Sulfasalazine and Endothelial Function
Not yet reported Boston University 60 participants Est. completion 2007-12 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT00572494
AMS INSIGHT 1 Study - Bioabsorbable Metal Stent Investigation in Chronic Limb Ischemia Treatment
Not yet reported Flanders Medical Research Program 117 participants Est. completion 2007-01 12 sitesOther conditions: Peripheral Artery DiseaseView official trial listing → -
Completed NCT NCT00579878
Triple III Comparison of Leflunomide Alone Versus Two DMARD Combinations in the Treatment of Rheumatoid Arthritis
Not yet reported University of Nebraska 69 participants Est. completion 2010-03-11 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Terminated NCT NCT00637780
Study To Determine The Pharmacokinetics Of Sulfasalazine In Children With Juvenile Idiopathic Arthritis
Not yet reported Pfizer 2 participants Est. completion 2014-01 2 sites Stand-aloneOther conditions: Arthritis, Juvenile RheumatoidView official trial listing → -
Terminated NCT NCT00706797
Study Evaluating Efficacy / Safety of Etanercept + Methotrexate Compared to Usual Treatment in Moderate RA Subjects
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 141 participants Est. completion 2010-05 45 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00720798
An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core Studies
Not yet reported Hoffmann-La Roche 2067 participants Est. completion 2013-04 295 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00764725
Comparison of MTX+Anti-TNF to MTX+Conventional DMARDs in Patients With Early Rheumatoid Arthritis (RA) Who Failed MTX Alone (SWEFOT)
Not yet reported Karolinska Institutet 487 participants Est. completion 2008-12Other conditions: Rheumatoid ArthritisView official trial listing → -
Status unknown NCT NCT00844142
Enbrel-Sulfasalazin-Early-Axial Spondyloarthritis (AS)
Not yet reported Charite University, Berlin, Germany 80 participants Est. completion 2013-07 9 sitesOther conditions: Moderate to Severe Active Axial SpondyloarthritisView official trial listing → -
Completed NCT NCT00848354
Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy
Not yet reported Pfizer 429 participants Est. completion 2013-04 33 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Status unknown NCT NCT00889694
Clinical Study of Tripterygium Capsule to Treat Early Ankylosing Spondylitis
Not yet reported, Not yet reported Sun Yat-sen University 80 participants Est. completion 2009-08Other conditions: Early Ankylosing SpondylitisView official trial listing → -
Status unknown NCT NCT00908089
TNF-blocking Therapy in Combination With Disease-modifying Antirheumatic Drugs in Early Rheumatoid Arthritis
Not yet reported University of Helsinki 100 participants Est. completion 2015-12 13 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00953979
Efficacy and Safety of Kunxian Capsule in Treatment Patients With Early Ankylosing Spondylitis
Not yet reported Gu Jieruo 126 participants Est. completion 2009-12 1 siteOther conditions: Ankylosing Spondylitis, TreatmentView official trial listing → -
Completed NCT NCT01015547
Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis
Not yet reported Helsinki University Central Hospital 60 participants Est. completion 2013-12 6 sites Stand-aloneOther conditions: Juvenile Idiopathic ArthritisView official trial listing → -
Completed NCT NCT01040195
Combination Disease-Modifying Antirheumatic Drugs (DMARDs) Versus Sulfasalazine in Inflammatory Back Pain
Not yet reported Sanjay Gandhi Postgraduate Institute of Medical Sciences 33 participants Est. completion 2012-12 1 siteOther conditions: Seronegative SpondyloarthropathiesView official trial listing → -
Completed NCT NCT01172639
Effectiveness in Daily Practice of Different Treatment Strategies for Early Rheumatoid Arthritis.
Not yet reported P. Verschueren 400 participants Est. completion 2015-06 17 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01198145
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Not yet reported Alliance for Clinical Trials in Oncology 87 participants Est. completion 2017-07-15 257 sites Stand-aloneOther conditions: Diarrhea, Gastrointestinal Complications, Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Completed NCT NCT01211834
Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis
Not yet reported JW Pharmaceutical 90 participants Est. completion 2010-10 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01256736
To Evaluate 1 Year Extension Study of the Efficacy and Safety of Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis
Not yet reported JW Pharmaceutical 89 participants Est. completion 2013-11 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01312129
Effects of Sulfasalazine on BOLD Response to Alcohol Cues
Not yet reported The Mind Research Network 23 participants Est. completion 2011-09 1 site Stand-aloneAlcohol use disorderView official trial listing → -
Completed NCT NCT01313208
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
Not yet reported Amgen 210 participants Est. completion 2013-05 47 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Status unknown NCT NCT01420432
Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Ankylosing Spondylitis (AS)
Not yet reported Shandong University 10 participants Est. completion 2013-12 1 site Stand-aloneOther conditions: Ankylosing SpondylitisView official trial listing → -
Status unknown NCT NCT01491815
Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose Reduction
Not yet reported Karolinska Institutet 812 participants Est. completion 2023-12 30 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01532648
Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 Milligrams (mg) in Participants With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA)
Not yet reported Bausch Health Americas, Inc. 510 participants Est. completion 2013-10-02 114 sites Stand-aloneOther conditions: Ulcerative ColitisView official trial listing → -
Completed NCT NCT01577966
Pilot Study Effect of Sulfasalazine on Glutamate Levels by(Magnetic Resonance Spectroscopy)MRS in Patients With Glioma
Not yet reported University of Alabama at Birmingham 9 participants Est. completion 2015-01 1 site Stand-aloneOther conditions: Brain TumorView official trial listing → -
Completed NCT NCT01596764
Effects of Methylnaltrexone in Comparison to Naloxone on Loperamide-induced Delay of the Oro-cecal, Whole-gut and Colon Transit Time.
Not yet reported University Medicine Greifswald 16 participants Est. completion 2012-01 1 siteOther conditions: Intestinal ObstructionView official trial listing → -
Completed NCT NCT01596777
Effects of 500 mg Immediate Release and Extended Release Methylnaltrexone on Loperamide-induced Delay of the Oro-cecal and Whole-gut Transit Time in Healthy Subjects
Not yet reported University Medicine Greifswald 15 participants Est. completion 2010-05 1 siteOther conditions: Intestinal ObstructionView official trial listing → -
Terminated NCT NCT01659242
Leflunomide Versus Sulfasalazine/Methotrexate in Rheumatoid Arthritis:an Ultrasound/Magnetic Resonance Imaging Study
Not yet reported Singapore General Hospital 1 participants 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Terminated NCT NCT01667029
Study of Sulfasalazine in Treating Painful Neuropathy
Not yet reported Massachusetts General Hospital 8 participants Est. completion 2017-08-10 1 site Stand-aloneOther conditions: Painful NeuropathyView official trial listing → -
Completed NCT NCT01689532
A Study of CNTO 136 (Sirukumab) Administered Subcutaneously in Japanese Patients With Active Rheumatoid Arthritis Unresponsive to Methotrexate or Sulfasalazine
Not yet reported Janssen Pharmaceutical K.K. 122 participants Est. completion 2015-03 17 sitesOther conditions: Arthritis, RheumatoidView official trial listing → -
Completed NCT NCT01709578
To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)
Not yet reported Sanofi 546 participants Est. completion 2015-03 196 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01768572
To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN)
Not yet reported Sanofi 202 participants Est. completion 2014-10 78 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01870128
Comparison of Three Different Treatment Regimes in Early Rheumatoid Arthritis: A Randomized Open-labelled Trial
Not yet reported All India Institute of Medical Sciences 60 participants Est. completion 2011-06 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01941095
A Study of Subcutaneous Tocilizumab as Monotherapy and/or in Combination With Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Rheumatoid Arthritis
Not yet reported Hoffmann-La Roche 100 participants Est. completion 2016-07-10 10 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT02057250
To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis
Not yet reported Sanofi 217 participants Est. completion 2016-03 53 sites Stand-aloneOther conditions: RAView official trial listing → -
Terminated NCT NCT02099240
Patients Response to Early Switch To Oral:Osteomyelitis Study
Not yet reported Julio Ramirez 11 participants Est. completion 2018-11-07 1 siteOther conditions: OsteomyelitisView official trial listing → -
Completed NCT NCT02219347
Biomarkers of Remission in Rheumatoid Arthritis (BioRRA)
Not yet reported Newcastle-upon-Tyne Hospitals NHS Trust 74 participants Est. completion 2017-08 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT02293590
RICE: Remission by Intra-articular Injection Plus CErtolizumab
Not yet reported Rüdiger B. Müller 43 participants Est. completion 2018-01-15 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Terminated NCT NCT02293681
An Observational Study of Infliximab in Participants Suffering From Ankylosing Spondylitis With Hip Involvement
Janssen Research & Development, LLC 76 participants Est. completion 2017-05-31 6 sitesOther conditions: Spondylitis, AnkylosingView official trial listing → -
Status unknown NCT NCT02320630
Combination Therapy Prevents the Relapse of RA
Not yet reported Peking University First Hospital 240 participants Est. completion 2020-09 1 siteOther conditions: Recurrence (Disease Attribute)View official trial listing → -
Completed NCT NCT02373202
A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA)
Not yet reported Sanofi 91 participants Est. completion 2016-11 40 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT02374021
Treatments Against RA and Effect on FDG-PET/CT
Not yet reported Brigham and Women's Hospital 159 participants Est. completion 2021-05 31 sitesOther conditions: Arthritis, RheumatoidView official trial listing → -
Completed NCT NCT02376478
On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection
Medical University of Vienna 222 participants Est. completion 2011-01Other conditions: Psoriasis, Inflammatory Bowel DiseasesView official trial listing → -
Completed NCT NCT02433184
Very Early Versus Delayed Etanercept in Patients With RA
Not yet reported University of Leeds 120 participants Est. completion 2019-07 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT02434861
An Open Label, Single Dose, Three Part Study to Assess the Effects of Rolapitant (2 mg/mL IV Solution) on the Pharmacokinetics of Digoxin; Sulfasalazine; and the Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and Dextromethorphan in Healthy Subjects
Not yet reported Tesaro, Inc. 102 participants Est. completion 2015-08 1 site Stand-aloneOther conditions: Chemotherapy-induced Nausea and VomitingView official trial listing → -
Completed NCT NCT02451748
IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA
Not yet reported University of Illinois at Chicago 32 participants Est. completion 2017-12 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Status unknown NCT NCT02456363
Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis
Not yet reported Chung Shan Medical University 300 participants Est. completion 2019-12 1 site Stand-aloneOther conditions: Ankylosing SpondylitisView official trial listing → -
Status unknown NCT NCT02466581
Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease Activity
Not yet reported Karolinska Institutet 25 participants Est. completion 2023-12 8 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Status unknown NCT NCT02634541
Adalimumab in Alleviating Inflammation in Patients With Axial Spondyloarthritis
Not yet reported University of Helsinki 60 participants Est. completion 2017-12 2 sites Stand-aloneOther conditions: Ankylosing SpondyloarthritisView official trial listing → -
Status unknown NCT NCT02638896
Dose Reduction of Etanercept in Patients With Ankylosing Spondylitis
Not yet reported Zhixiang Huang 100 participants Est. completion 2017-04 Stand-aloneOther conditions: Ankylosing SpondylitisView official trial listing → -
Status unknown NCT NCT02779114
RETRO (REduction of Therapy in RA Patients in Ongoing Remission)
Not yet reported University of Erlangen-Nürnberg Medical School 318 participants Est. completion 2018-06 12 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT02873936
Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) Treatment
Not yet reported Gilead Sciences 449 participants Est. completion 2018-06-26 104 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Terminated NCT NCT02930343
Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate Monotherapy
Not yet reported Jawaharlal Institute of Postgraduate Medical Education & Research 136 participants Est. completion 2018-08 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT03012763
Oral Pharmacokinetics of Sulfasalazine, Paracetamol, Fexofenadine and Valsartan Using Different Administration Mediums
Not yet reported University Medicine Greifswald 9 participantsOther conditions: Pharmacokinetics, Magnetic Resonance Imaging, Administration, OralView official trial listing → -
Completed NCT NCT03254589
Methotrexate, Blood Pressure and Arterial Function in Rheumatoid Arthritis
Not yet reported Flinders University 124 participants Est. completion 2023-12-31 1 site Stand-aloneOther conditions: Rheumatoid Arthritis, Stiffness, Aortic, Endothelial Dysfunction, Cardiovascular Risk FactorView official trial listing → -
Completed NCT NCT03411798
Sequential Application of Yisaipu® and DMARDs in Treating Mild-to-Moderate AS
Not yet reported Nanfang Hospital, Southern Medical University 76 participants Est. completion 2019-07-01 1 site Stand-aloneOther conditions: Ankylosing SpondylitisView official trial listing → -
Status unknown NCT NCT03440892
Effects of Antirheumatic Treatment on Levels of Survivin in Rheumatoid Arthritis Patients
Vastra Gotaland Region 2500 participants Est. completion 2025-01 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT03449758
Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis
Not yet reported Sanofi 84 participants Est. completion 2019-07-31 33 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT03531073
Multicentre ObservatioNal Initiative in Treat to Target Outcomes in Psoriatic Arthritis
University of Oxford 446 participants Est. completion 2024-12-31 1 siteOther conditions: Psoriatic ArthritisView official trial listing → -
Completed NCT NCT03561584
Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis
Not yet reported Brigham and Women's Hospital 32 participants Est. completion 2026-03-03 1 siteOther conditions: Primary Sclerosing CholangitisView official trial listing → -
Status unknown NCT NCT03610217
Pragmatic Clinical Trials in Scleroderma
Not yet reported University of West London 400 participants Est. completion 2021-10 1 site Stand-aloneOther conditions: Scleroderma, Systemic, Sclerosis, SystemicView official trial listing → -
Completed NCT NCT03660059
A Study to Assess Safety and Efficacy of ASP015K in Participants With Rheumatoid Arthritis (RA) Who Had an Inadequate Response or Intolerance to Methotrexate (MTX)
Not yet reported Astellas Pharma China, Inc. 385 participants Est. completion 2021-11-02 43 sitesOther conditions: Rheumatoid Arthritis (RA)View official trial listing → -
Completed NCT NCT03734627
Gastrointestinal Nutrient Transit and Enteroendocrine Function After Upper Gastrointestinal Surgery
St. James's Hospital, Ireland 40 participants Est. completion 2021-07-01 2 sitesOther conditions: Esophageal Cancer, Nutrition Disorders, Appetite Disorders, Dumping Syndrome, Delayed Gastric Emptying, SurgeryView official trial listing → -
Completed NCT NCT03739853
Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED Trial
Not yet reported University of Oxford 192 participants Est. completion 2024-10-31 1 site Stand-aloneOther conditions: Psoriatic ArthritisView official trial listing → -
Completed NCT NCT03797872
Psoriatic Oligoarthritis Intervention With Symptomatic thErapy
Not yet reported University of Oxford 1 participants Est. completion 2020-07-16 1 siteOther conditions: Psoriatic ArthritisView official trial listing → -
Completed NCT NCT03801733
Drug-Drug Interaction Study of Vadadustat With Rosuvastatin, Sulfasalazine, Pravastatin, Atorvastatin and Simvastatin
Not yet reported Akebia Therapeutics 134 participants Est. completion 2018-11-24 1 site Stand-aloneOther conditions: Drug Interaction PotentiationView official trial listing → -
Status unknown NCT NCT03813771
Targeted Treatment Early With Etanercept + Methotrexate vs.T2T Care for DMARD-naïve Early RA Patients Based on naïve T-cell Stratification
Not yet reported University of Leeds 106 participants Est. completion 2023-02 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT03847311
Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients
Not yet reported University of Arizona 7 participants Est. completion 2023-10-09 2 sitesOther conditions: Breast Cancer, Chronic Pain Due to Malignancy (Finding)View official trial listing → -
Status unknown NCT NCT03863405
Metformin Use in Rheumatoid Arthritis
Not yet reported Ain Shams University 60 participants Est. completion 2020-01-09 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Status unknown NCT NCT04066803
Optimal MTX Dose With Folic Acid Randomized Case-control Trial
Not yet reported Sun Yat-sen University 160 participants Est. completion 2020-07-30 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Status unknown NCT NCT04077957
Treat-to-target Strategy in Ankylosing Spondylitis Using Etanercept and Conventional Synthetic DMARDs
Not yet reported Nanfang Hospital, Southern Medical University 100 participants Est. completion 2022-07-02 1 site Stand-aloneOther conditions: Ankylosing Spondylitis, SpondyloarthritisView official trial listing → -
Completed NCT NCT04205357
Sulfasalazine and Stereotactic Radiosurgery for Recurrent Glioblastoma
Not yet reported Haukeland University Hospital 24 participants Est. completion 2022-10-14 1 siteOther conditions: Glioma, Glioblastoma, Recurrent GlioblastomaView official trial listing → -
Completed NCT NCT04268394
A Study to Evaluate Potential Cytochrome P450 and Transporter Protein Interactions With CC-99677
Not yet reported Celgene 48 participants Est. completion 2021-06-02 1 site Stand-aloneOther conditions: Healthy VolunteerView official trial listing → -
Status unknown NCT NCT04400786
A Randomized Open-labeled Study for Comparing Methods of Using Imrecoxib to Treat AS
Not yet reported Shanghai Zhongshan Hospital 196 participants Est. completion 2022-06-30 1 site Stand-aloneOther conditions: Ankylosing Spondylitis, Therapeutic Agent ToxicityView official trial listing → -
Withdrawn NCT NCT04434118
Anti-rheumatic Drug Use and Risk of COVID-19 Infection in Rheumatoid Arthritis Patients
Sadat City University Est. completion 2021-12-30 1 siteOther conditions: Rheumatoid Arthritis, COVIDView official trial listing → -
Active, not recruiting NCT NCT04435288
Spondyloarthritis: Inducing Drug-free Remission by Early TNF-alpha Blockade
Not yet reported University Hospital, Ghent 90 participants Est. completion 2028-12-31 6 sitesOther conditions: Peripheral SpondyloarthritisView official trial listing → -
Completed NCT NCT04499495
Assessment of 5-Aminosalicylic Acid Prescription Patterns and Treatment Outcomes in Patients With Ulcerative Colitis in Korea
Ferring Pharmaceuticals 11385 participants Est. completion 2022-07-31 1 siteOther conditions: Ulcerative ColitisView official trial listing → -
Status unknown NCT NCT04528056
Pilot Study of the Safety and Efficacy of Sulfasalazine in Pulmonary Arterial Hypertension
Not yet reported, Not yet reported RenJi Hospital 80 participants Est. completion 2022-10-31 1 site Stand-aloneOther conditions: Pulmonary Arterial HypertensionView official trial listing → -
Status unknown NCT NCT04610476
Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis
Not yet reported University of Erlangen-Nürnberg Medical School 270 participants Est. completion 2025-10-19 1 site Stand-aloneOther conditions: Psoriatic Arthritis, Withdrawal, ReductionView official trial listing → -
Completed NCT NCT04720183
Drug-drug Interaction Study with GLPG3970 and Sulfasalazine in Adult, Healthy Subjects
Not yet reported Lakefront Biotherapeutics NV 8 participants Est. completion 2021-04-23 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT04927000
The Role of Tofacitinib in Steroid Withdrawal in Rheumatoid Arthritis
Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 170 participants Est. completion 2023-12-30 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT05051137
Real-World Emulation of the SWEFOT Trial
Karolinska Institutet 509 participants Est. completion 2020-11-16 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Status unknown NCT NCT05424393
Real-World Study on Long-term Treatment With YISAIPU for Fujian RA Patients
The First Affiliated Hospital of Xiamen University 500 participants Est. completion 2025-12-31 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT05445440
A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of Sulfasalazine
Not yet reported Bristol-Myers Squibb 30 participants Est. completion 2022-11-23 1 site Stand-aloneOther conditions: Healthy ParticipantsView official trial listing → -
Completed NCT NCT05447520
Montelukast Use in Rheumatoid Arthritis
Not yet reported Noha Mansour 92 participants Est. completion 2022-12-30 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT05458531
Monitoring of Inflammatory Conditions
University of Nottingham 664 participants Est. completion 2023-02-08 1 siteOther conditions: Inflammatory Disease, Crohn Disease, Ulcerative Colitis, Rheumatoid Arthritis, System; Lupus Erythematosus, Psoriatic Arthritis, Reactive Arthritis, Inflammatory Arthritis, PsoriasisView official trial listing → -
Completed NCT NCT05671497
The Effect of Cilostazol on Rheumatoid Arthritis Patients
Not yet reported, Not yet reported Ain Shams University 70 participants Est. completion 2024-10-01 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT05749068
Evaluation of the CapScan Device to Measure the Metabolism of Sulfasalazine
Not yet reported Envivo Bio Inc 10 participants Est. completion 2022-10-30 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT05871086
Coenzyme Q10 in Juvenile Idiopathic Arthritis Patients
Not yet reported, Not yet reported Nourhan Elsherif 60 participants Est. completion 2023-12 1 site Stand-aloneOther conditions: Juvenile Idiopathic ArthritisView official trial listing → -
Status unknown NCT NCT06060301
Topical Sulfasalazine and Oral Lichen Planus
Not yet reported Cairo University 46 participants Est. completion 2024-10-20 1 site Stand-aloneOther conditions: Oral Lichen Planus, Topical Sulfasalazine, CorticosteroidsView official trial listing → -
Status unknown NCT NCT06360068
A Prospective, Single Arm, Open Label, Proof of Concept Clinical Study of Sulfasalazine in the Treatment of Active Systemic Lupus Erythematosus
Not yet reported Qiong Fu 20 participants Est. completion 2025-05-01 Stand-aloneOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Not yet recruiting NCT NCT06557330
MRD Guided De-intensification of Bendamustine/Rituximab for Indolent Non-Hodgkin Lymphoma
Not yet reported Fox Chase Cancer Center 24 participants Est. completion 2028-03-30Other conditions: Lymphoma, Indolent Non-hodgkin LymphomaView official trial listing → -
Completed NCT NCT06594822
Effectiveness of Probiotics in Patients of Mild to Moderate Rheumatoid Arthritis
Not yet reported King Edward Medical University 88 participants Est. completion 2024-02-23 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT06637683
Efficacy of LiveSpo COLON as a Supportive Treatment for Inflammatory Bowel Disease (IBD)
Not yet reported Anabio R&D 60 participants Est. completion 2020-06-20 1 site Stand-aloneOther conditions: Inflammatory Bowel DiseasesView official trial listing → -
Completed NCT NCT06985134
Comparative Efficacy and Safety of Thalidomide and Sulfasalazine in Moderate to Severe Ankylosing Spondylitis: A Real-World Study From Bangladesh
Not yet reported Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 93 participants Est. completion 2018-12-31 1 site Stand-aloneOther conditions: Comparative Efficacy and Safety of Thalidomide and Sulfasalazine in Moderate to Severe Ankylosing Spondylitis: A Real-World Study From Bangladesh, Condition ...Moderate to Severe Axial SpondyloarthopathyView official trial listing → -
Not yet recruiting NCT NCT07497282
Venlafaxine as Adjunct Therapy in Rheumatoid Arthritis
Not yet reported Ain Shams University 70 participants Est. completion 2026-12-26Other conditions: Rheumatoid ArthritisView official trial listing → -
Not yet recruiting NCT NCT07730723
The Effect of Nicorandil on Rheumatoid Arthritis Patients
Not yet reported, Not yet reported Ain Shams University 70 participants Est. completion 2027-07 1 siteOther conditions: Rheumatoid Arthritis (RA)View official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.